1. Home
  2. VKTX
  3. VKTX News

Latest Viking Therapeutics Inc. (VKTX) News on October 18, 2024

Viking Therapeutics Gives Investors Another Reason to Remain Bullish on Its Future
VKTX

Motley Fool

14 hours ago

Viking Therapeutics Gives Investors Another Reason to Remain Bullish on Its Future

Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know
VKTX

Zacks

a day ago

Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know

Viking Therapeutics to Report Financial Results for Third Quarter 2024 on October 23, 2024
VKTX

PR Newswire

a day ago

Viking Therapeutics to Report Financial Results for Third Quarter 2024 on October 23, 2024

Why Amgen's Obesity Drug — And $5 Billion Opportunity — Led To A Downgrade
VKTX

Investor's Business Daily

3 days ago

Why Amgen's Obesity Drug — And $5 Billion Opportunity — Led To A Downgrade

Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views?
VKTX

Zacks

4 days ago

Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views?

Where Will Viking Therapeutics Be in 5 Years?
VKTX

Motley Fool

4 days ago

Where Will Viking Therapeutics Be in 5 Years?

Better Biotech Stock to Buy With $1,500 Right Now: Viking Therapeutics vs. Summit Therapeutics
VKTX

Motley Fool

4 days ago

Better Biotech Stock to Buy With $1,500 Right Now: Viking Therapeutics vs. Summit Therapeutics

With 74% institutional ownership, Viking Therapeutics, Inc. (NASDAQ:VKTX) is a favorite amongst the big guns
VKTX

Simply Wall St.

5 days ago

With 74% institutional ownership, Viking Therapeutics, Inc. (NASDAQ:VKTX) is a favorite amongst the big guns

The Ultimate Biotech Stock to Buy With $100 Right Now
VKTX

Motley Fool

6 days ago

The Ultimate Biotech Stock to Buy With $100 Right Now

Here's Why Viking Therapeutics, Inc. (VKTX) Fell More Than Broader Market
VKTX

Zacks

7 days ago

Here's Why Viking Therapeutics, Inc. (VKTX) Fell More Than Broader Market

Viking reports data from X-linked adrenoleukodystrophy trial
VKTX

Clinical Trials Arena

8 days ago

Viking reports data from X-linked adrenoleukodystrophy trial

Viking Therapeutics Reveals Encouraging Data From Genetic Disorder Drug Study, Analyst Says Focus On Orphan Disease Broadens Viking's Potential Revenue Streams
VKTX

Benzinga

9 days ago

Viking Therapeutics Reveals Encouraging Data From Genetic Disorder Drug Study, Analyst Says Focus On Orphan Disease Broadens Viking's Potential Revenue Streams

VKTX

MT Newswires

9 days ago

Sector Update: Health Care Stocks Steady Pre-Bell Wednesday

VKTX

MT Newswires

9 days ago

Viking Therapeutics Shares up After "Positive" Results in Trial of Potential Brain Disease Treatment

Viking Therapeutics Announces Results from Phase 1b Clinical Trial of VK0214 in Patients with X-ALD
VKTX

PR Newswire

9 days ago

Viking Therapeutics Announces Results from Phase 1b Clinical Trial of VK0214 in Patients with X-ALD

Viking Therapeutics, Inc. (VKTX): A Hot Stock to Buy Now
VKTX

Insider Monkey

10 days ago

Viking Therapeutics, Inc. (VKTX): A Hot Stock to Buy Now

2 Soaring Stocks That Could Climb Another 112% and 120%, According to Wall Street Analysts
VKTX

Motley Fool

11 days ago

2 Soaring Stocks That Could Climb Another 112% and 120%, According to Wall Street Analysts

Viking Therapeutics, Inc. (VKTX) Rises Higher Than Market: Key Facts
VKTX

Zacks

13 days ago

Viking Therapeutics, Inc. (VKTX) Rises Higher Than Market: Key Facts

As Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, Pfizer
VKTX

Investor's Business Daily

14 days ago

As Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, Pfizer

Why Viking Therapeutics, Inc. (VKTX) Dipped More Than Broader Market Today
VKTX

Zacks

14 days ago

Why Viking Therapeutics, Inc. (VKTX) Dipped More Than Broader Market Today

Weight loss drug breakthroughs, gene therapies, and more: 8 clinical trials to watch right now
VKTX

Quartz

16 days ago

Weight loss drug breakthroughs, gene therapies, and more: 8 clinical trials to watch right now

Why Viking Therapeutics Stock Topped the Market Today
VKTX

Motley Fool

17 days ago

Why Viking Therapeutics Stock Topped the Market Today

Is Viking Therapeutics Stock a Buy?
VKTX

Motley Fool

19 days ago

Is Viking Therapeutics Stock a Buy?

Is Viking Therapeutics, Inc. (VKTX) the Best Performing Long Term Stock in 2024?
VKTX

Insider Monkey

19 days ago

Is Viking Therapeutics, Inc. (VKTX) the Best Performing Long Term Stock in 2024?

Better Rising Biotech: Viking Therapeutics vs. Summit Therapeutics
VKTX

Motley Fool

20 days ago

Better Rising Biotech: Viking Therapeutics vs. Summit Therapeutics

Viking Therapeutics, Inc. (VKTX) Falls More Steeply Than Broader Market: What Investors Need to Know
VKTX

Zacks

20 days ago

Viking Therapeutics, Inc. (VKTX) Falls More Steeply Than Broader Market: What Investors Need to Know

Is Viking Therapeutics Inc. (VKTX) the Best Performing Small-Cap Stock in 2024?
VKTX

Insider Monkey

21 days ago

Is Viking Therapeutics Inc. (VKTX) the Best Performing Small-Cap Stock in 2024?

Why Viking Therapeutics Stock Was So Healthy on Wednesday
VKTX

Motley Fool

22 days ago

Why Viking Therapeutics Stock Was So Healthy on Wednesday

Viking Therapeutics, Inc. (VKTX) Ascends While Market Falls: Some Facts to Note
VKTX

Zacks

22 days ago

Viking Therapeutics, Inc. (VKTX) Ascends While Market Falls: Some Facts to Note

Amgen vs. Viking Therapeutics: What's the Better GLP-1 Stock to Buy?
VKTX

Motley Fool

25 days ago

Amgen vs. Viking Therapeutics: What's the Better GLP-1 Stock to Buy?

VKTX

MT Newswires

25 days ago

Viking Therapeutics Insider Sold Shares Worth $715,850, According to a Recent SEC Filing

VKTX

MT Newswires

25 days ago

Viking Therapeutics Insider Sold Shares Worth $15,308,553, According to a Recent SEC Filing

Viking Therapeutics, Inc. (VKTX): Biotech Breakthrough or Short Sellers’ Target?
VKTX

Insider Monkey

a month ago

Viking Therapeutics, Inc. (VKTX): Biotech Breakthrough or Short Sellers’ Target?

Why Novo Nordisk Stock Fell While Eli Lilly and Viking Therapeutics Bumped Higher Today
VKTX

Motley Fool

a month ago

Why Novo Nordisk Stock Fell While Eli Lilly and Viking Therapeutics Bumped Higher Today

High-Flying Novo Nordisk Dips On Disappointing Data for Weight-Loss Pill
VKTX

The Wall Street Journal

a month ago

High-Flying Novo Nordisk Dips On Disappointing Data for Weight-Loss Pill

Viking Therapeutics, Inc. (VKTX) Exceeds Market Returns: Some Facts to Consider
VKTX

Zacks

a month ago

Viking Therapeutics, Inc. (VKTX) Exceeds Market Returns: Some Facts to Consider

Missed Out on Viking Therapeutics? Buy This Weight Loss Biotech Stock Right Now.
VKTX

Motley Fool

a month ago

Missed Out on Viking Therapeutics? Buy This Weight Loss Biotech Stock Right Now.

Jim Cramer: 'Hold On' To Builders FirstSource, 'Here's The Problem' With Viking Therapeutics
VKTX

Benzinga

a month ago

Jim Cramer: 'Hold On' To Builders FirstSource, 'Here's The Problem' With Viking Therapeutics

These 2 Biotech Stocks Are Set to Soar
VKTX

Motley Fool

a month ago

These 2 Biotech Stocks Are Set to Soar

Viking Therapeutics: A Bad Result for Roche's Weight-Management Pill Is Great News for Oral VK2735
VKTX

Motley Fool

a month ago

Viking Therapeutics: A Bad Result for Roche's Weight-Management Pill Is Great News for Oral VK2735

Why Investors Plowed Into Viking Therapeutics Stock Today
VKTX

Motley Fool

a month ago

Why Investors Plowed Into Viking Therapeutics Stock Today

NVO Oral Obesity Pill Tops Wegovy; LLY, VKTX, GPCR Stocks Rise
VKTX

Zacks

a month ago

NVO Oral Obesity Pill Tops Wegovy; LLY, VKTX, GPCR Stocks Rise

Novo Nordisk Stock Rises as Oral Obesity Pill Outshines Wegovy
VKTX

Zacks

a month ago

Novo Nordisk Stock Rises as Oral Obesity Pill Outshines Wegovy

Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic?
VKTX

Zacks

a month ago

Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic?

3 No-Brainer Biotech Stocks to Buy With $200 Right Now
VKTX

Motley Fool

a month ago

3 No-Brainer Biotech Stocks to Buy With $200 Right Now

Why Viking Therapeutics Stock Rocked the Market Today
VKTX

Motley Fool

a month ago

Why Viking Therapeutics Stock Rocked the Market Today

Why Analysts Predict a November Surge for Viking Therapeutics Stock
VKTX

Investopedia

a month ago

Why Analysts Predict a November Surge for Viking Therapeutics Stock

JPMorgan initiates coverage on GLP-1 entrant Viking Therapeutics
VKTX

Yahoo Finance Video

a month ago

JPMorgan initiates coverage on GLP-1 entrant Viking Therapeutics

VKTX

MT Newswires

a month ago

JPMorgan Initiates Viking Therapeutics at Overweight With $80 Price Target

Why you Should Buy the 200-day Dip in ARM, MSTR, VKTX
VKTX

Zacks

a month ago

Why you Should Buy the 200-day Dip in ARM, MSTR, VKTX

Viking Therapeutics, Inc. (VKTX) Laps the Stock Market: Here's Why
VKTX

Zacks

a month ago

Viking Therapeutics, Inc. (VKTX) Laps the Stock Market: Here's Why

Billionaires Are Buying Viking Therapeutics Stock Left and Right. Should You Follow Their Lead?
VKTX

Motley Fool

a month ago

Billionaires Are Buying Viking Therapeutics Stock Left and Right. Should You Follow Their Lead?

Prediction: This Biotech Stock Will Outperform Nvidia in the Second Half of the Year
VKTX

Motley Fool

a month ago

Prediction: This Biotech Stock Will Outperform Nvidia in the Second Half of the Year

Viking Therapeutics, Inc. (VKTX) Sees a More Significant Dip Than Broader Market: Some Facts to Know
VKTX

Zacks

a month ago

Viking Therapeutics, Inc. (VKTX) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Several Factors Negatively Impacted Viking Therapeutics (VKTX) in Q2
VKTX

Insider Monkey

a month ago

Several Factors Negatively Impacted Viking Therapeutics (VKTX) in Q2

The Best Biotech Stock to Invest $1,000 in Right Now
VKTX

Motley Fool

a month ago

The Best Biotech Stock to Invest $1,000 in Right Now

Viking Surges 342% in the Past Year: How Should You Play the Stock?
VKTX

Zacks

a month ago

Viking Surges 342% in the Past Year: How Should You Play the Stock?

The 10 Pharma Stocks To Watch — Including Viking, Roche And Amgen — Amid The Fast-Growing Obesity Drug Race
VKTX

Investor's Business Daily

2 months ago

The 10 Pharma Stocks To Watch — Including Viking, Roche And Amgen — Amid The Fast-Growing Obesity Drug Race

The 9 Pharma Stocks To Watch — Including Viking, Roche And Amgen — Amid The Fast-Growing Obesity Drug Race
VKTX

Investor's Business Daily

2 months ago

The 9 Pharma Stocks To Watch — Including Viking, Roche And Amgen — Amid The Fast-Growing Obesity Drug Race

Viking Therapeutics (VKTX) Fell Amid Rising Competition
VKTX

Insider Monkey

2 months ago

Viking Therapeutics (VKTX) Fell Amid Rising Competition

Bioventus and Pool have been highlighted as Zacks Bull and Bear of the Day
VKTX

Zacks

2 months ago

Bioventus and Pool have been highlighted as Zacks Bull and Bear of the Day

Viking Therapeutics to Participate at Morgan Stanley 22nd Annual Global Healthcare Conference
VKTX

PR Newswire

2 months ago

Viking Therapeutics to Participate at Morgan Stanley 22nd Annual Global Healthcare Conference

Eli Lilly Launches Discounted Versions of Obesity Drug Zepbound
VKTX

Zacks

2 months ago

Eli Lilly Launches Discounted Versions of Obesity Drug Zepbound

Why Viking Therapeutics Stock Price Moved Down 6% on Tuesday
VKTX

Zacks

2 months ago

Why Viking Therapeutics Stock Price Moved Down 6% on Tuesday

Viking Therapeutics, Inc. (VKTX): One of Oppenheimer’s Top Stock Picks For the Next 12 Months
VKTX

Insider Monkey

2 months ago

Viking Therapeutics, Inc. (VKTX): One of Oppenheimer’s Top Stock Picks For the Next 12 Months

Why Viking Therapeutics Stock Got Thrashed on Tuesday
VKTX

Motley Fool

2 months ago

Why Viking Therapeutics Stock Got Thrashed on Tuesday

Eli Lilly Halves Zepbound Price In New Version Of Weight-Loss Drug
VKTX

Investor's Business Daily

2 months ago

Eli Lilly Halves Zepbound Price In New Version Of Weight-Loss Drug

Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet
VKTX

Zacks

2 months ago

Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet

Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030
VKTX

Motley Fool

2 months ago

Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030

Viking Therapeutics Stock Could Rocket 76% Higher According to Wall Street. Is It a Buy Now?
VKTX

Motley Fool

2 months ago

Viking Therapeutics Stock Could Rocket 76% Higher According to Wall Street. Is It a Buy Now?

Why Viking Therapeutics could be 'onto something pretty amazing'
VKTX

Yahoo Finance

2 months ago

Why Viking Therapeutics could be 'onto something pretty amazing'

Viking (VKTX) Rises 25% in a Month: Should You Buy or Wait?
VKTX

Zacks

2 months ago

Viking (VKTX) Rises 25% in a Month: Should You Buy or Wait?

Director J Singleton Sells 5,700 Shares of Viking Therapeutics Inc (VKTX)
VKTX

GuruFocus.com

2 months ago

Director J Singleton Sells 5,700 Shares of Viking Therapeutics Inc (VKTX)

Viking Therapeutics could be a new winner in the GLP-1 space
VKTX

Yahoo Finance Video

2 months ago

Viking Therapeutics could be a new winner in the GLP-1 space

Zacks Investment Ideas feature highlights: Viking Therapeutics, McDonalds, Starbucks, Novo Nordisk and Eli Lilly
VKTX

Zacks

2 months ago

Zacks Investment Ideas feature highlights: Viking Therapeutics, McDonalds, Starbucks, Novo Nordisk and Eli Lilly

Massive Weight Loss Market: Viking (VKTX) is Best-in-Breed
VKTX

Zacks

2 months ago

Massive Weight Loss Market: Viking (VKTX) is Best-in-Breed

VKTX

MT Newswires

2 months ago

Viking Therapeutics Insider Sold Shares Worth $7,426,508, According to a Recent SEC Filing

Director J Singleton Sells 16,000 Shares of Viking Therapeutics Inc (VKTX)
VKTX

GuruFocus.com

2 months ago

Director J Singleton Sells 16,000 Shares of Viking Therapeutics Inc (VKTX)

Could Viking Therapeutics Become the Next Novo Nordisk?
VKTX

Motley Fool

2 months ago

Could Viking Therapeutics Become the Next Novo Nordisk?

Why Is Viking Therapeutics, Inc. (VKTX) the Best Diabetes Stock to Buy Now?
VKTX

Insider Monkey

2 months ago

Why Is Viking Therapeutics, Inc. (VKTX) the Best Diabetes Stock to Buy Now?

VKTX

MT Newswires

2 months ago

Viking Therapeutics Insider Sold Shares Worth $1,195,736, According to a Recent SEC Filing

Director J Singleton Sells 20,786 Shares of Viking Therapeutics Inc (VKTX)
VKTX

GuruFocus.com

2 months ago

Director J Singleton Sells 20,786 Shares of Viking Therapeutics Inc (VKTX)

What Eli Lilly, Novo Nordisk earnings reveal about the future of GLP-1 sales
VKTX

Yahoo Finance

2 months ago

What Eli Lilly, Novo Nordisk earnings reveal about the future of GLP-1 sales

Is Viking Therapeutics, Inc. (VKTX) a Good Addition to Your Portfolio Right Now?
VKTX

Insider Monkey

2 months ago

Is Viking Therapeutics, Inc. (VKTX) a Good Addition to Your Portfolio Right Now?

Morgan Stanley Predicts up to ~230% Surge for These 2 ‘Strong Buy’ Stocks
VKTX

TipRanks

2 months ago

Morgan Stanley Predicts up to ~230% Surge for These 2 ‘Strong Buy’ Stocks

3 Unstoppable Stocks to Buy in August
VKTX

Motley Fool

2 months ago

3 Unstoppable Stocks to Buy in August

Viking Therapeutics (VKTX) Cooled Down After Strong Q1
VKTX

Insider Monkey

3 months ago

Viking Therapeutics (VKTX) Cooled Down After Strong Q1

Are Eli Lilly and Novo Nordisk Too Expensive For You? Here Are 4 Other Potential Weight Loss Stocks You May Want to Consider Right Now.
VKTX

Motley Fool

3 months ago

Are Eli Lilly and Novo Nordisk Too Expensive For You? Here Are 4 Other Potential Weight Loss Stocks You May Want to Consider Right Now.

VKTX

Argus Research

3 months ago

Daily – Vickers Top Buyers & Sellers for 08/01/2024

Better Weight Loss Drug Stock: Viking Therapeutics vs. Zealand Pharma
VKTX

Motley Fool

3 months ago

Better Weight Loss Drug Stock: Viking Therapeutics vs. Zealand Pharma

Wall Street is still jittery on GLP-1s
VKTX

Yahoo Finance

3 months ago

Wall Street is still jittery on GLP-1s

The Bull Case for Viking Therapeutics Just Got Even Stronger. Here's Why You Should Buy It.
VKTX

Motley Fool

3 months ago

The Bull Case for Viking Therapeutics Just Got Even Stronger. Here's Why You Should Buy It.

Weight Loss Drug Stocks Just Took a Hit. Should You Buy the Stock That Caused It?
VKTX

Motley Fool

3 months ago

Weight Loss Drug Stocks Just Took a Hit. Should You Buy the Stock That Caused It?

Attention, Growth Investors: This Biotech Stock Is Crushing Nvidia.
VKTX

Motley Fool

3 months ago

Attention, Growth Investors: This Biotech Stock Is Crushing Nvidia.

Is Viking Therapeutics a Millionaire-Maker Stock?
VKTX

Motley Fool

3 months ago

Is Viking Therapeutics a Millionaire-Maker Stock?

June PCE inflation print, auto earnings: Morning Brief
VKTX

Yahoo Finance Video

3 months ago

June PCE inflation print, auto earnings: Morning Brief

Viking’s new dual GLP-1R/GIPR agonist expected to start Phase III trials soon
VKTX

Clinical Trials Arena

3 months ago

Viking’s new dual GLP-1R/GIPR agonist expected to start Phase III trials soon

Eli Lilly loses $120B in value over Viking's GLP-1 progress
VKTX

Yahoo Finance Video

3 months ago

Eli Lilly loses $120B in value over Viking's GLP-1 progress

Why Weight Loss Drug Developer Stocks Tumbled on Thursday
VKTX

Motley Fool

3 months ago

Why Weight Loss Drug Developer Stocks Tumbled on Thursday

VKTX

MT Newswires

3 months ago

Top Midday Gainers

Share on Social Networks: